This applies to all new innovative medicines, as well as new indications, pharmaceutical forms and routes of administration for existing patent-protected (and supplementary protection certificate-protected) medicines
Seda nõuet kohaldatakse nii kõigi uute ravimite suhtes kui ka uute näidustuste,